{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:41:49Z","timestamp":1792590109111,"version":"4.5.0"},"reference-count":148,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-10425-2","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T04:20:48Z","timestamp":1742185248000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Antibiotic-induced gut dysbiosis: unraveling the gut-heart axis and its impact on cardiovascular health"],"prefix":"10.1007","volume":"52","author":[{"given":"Navpreet","family":"Kaur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahadev","family":"Dhami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2450-2975","authenticated-orcid":false,"given":"Khadga Raj","family":"Aran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,17]]},"reference":[{"issue":"2","key":"10425_CR1","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3390\/metabo15020138","volume":"15","author":"L Blok","year":"2025","unstructured":"Blok L, Hanssen N, Nieuwdorp M, Rampanelli E (2025) From microbes to metabolites: advances in gut Microbiome research in type 1 diabetes. Metabolites 15(2):138. https:\/\/doi.org\/10.3390\/metabo15020138","journal-title":"Metabolites"},{"issue":"6","key":"10425_CR2","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1080\/10408398.2020.1843396","volume":"62","author":"H Duan","year":"2022","unstructured":"Duan H, Yu L, Tian F, Zhai Q, Fan L, Chen W (2022) Antibiotic-induced gut dysbiosis and barrier disruption and the potential protective strategies. Crit Rev Food Sci Nutr 62(6):1427\u20131452. https:\/\/doi.org\/10.1080\/10408398.2020.1843396","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"49","key":"10425_CR3","doi-asserted-by":"publisher","first-page":"e2411919121","DOI":"10.1073\/pnas.2411919121","volume":"121","author":"EY Klein","year":"2024","unstructured":"Klein EY, Impalli I, Poleon S, Denoel P, Cipriano M, Van Boeckel TP, Pecetta S, Bloom DE, Nandi A (2024) Global trends in antibiotic consumption during 2016\u20132023 and future projections through 2030. PNAS 121(49):e2411919121. https:\/\/doi.org\/10.1073\/pnas.2411919121","journal-title":"PNAS"},{"issue":"10","key":"10425_CR4","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1097\/CM9.0000000000000245","volume":"132","author":"S Zhang","year":"2019","unstructured":"Zhang S, Chen DC (2019) Facing a new challenge: the adverse effects of antibiotics on gut microbiota and host immunity. Chin Med J 132(10):1135\u20131138. https:\/\/doi.org\/10.1097\/CM9.0000000000000245","journal-title":"Chin Med J"},{"key":"10425_CR5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13099-025-00683-7","volume":"17","author":"AY Ali","year":"2025","unstructured":"Ali AY, Zahran SA, Eissa M, Kashef MT, Ali AE (2025) Gut microbiota dysbiosis and associated immune response in systemic lupus erythematosus: impact of disease and treatment. Gut Pathog 17:10. https:\/\/doi.org\/10.1186\/s13099-025-00683-7","journal-title":"Gut Pathog"},{"key":"10425_CR6","doi-asserted-by":"publisher","first-page":"1326436","DOI":"10.3389\/fendo.2023.1326436","volume":"14","author":"L Zhang","year":"2024","unstructured":"Zhang L, Yu C, Wang T, Zhou W, Bao H, Cheng X (2024) Association of the metabolic score for insulin resistance with cardiovascular diseases, cardiovascular and all-cause mortality in Chinese hypertensive population. Front Endocrinol 14:1326436. https:\/\/doi.org\/10.3389\/fendo.2023.1326436","journal-title":"Front Endocrinol"},{"key":"10425_CR7","doi-asserted-by":"publisher","first-page":"156178","DOI":"10.1016\/j.scitotenv.2022.156178","volume":"838","author":"G Huang","year":"2022","unstructured":"Huang G, Qu Q, Wang M, Huang M, Zhou W, Wei F (2022) Global landscape of gut Microbiome diversity and antibiotic resistomes across vertebrates. Sci Total Environ 838:156178. https:\/\/doi.org\/10.1016\/j.scitotenv.2022.156178","journal-title":"Sci Total Environ"},{"key":"10425_CR8","doi-asserted-by":"publisher","first-page":"108991","DOI":"10.1016\/j.jnutbio.2022.108991","volume":"105","author":"L Anto","year":"2022","unstructured":"Anto L, Blesso CN (2022) Interplay between diet, the gut microbiome, and atherosclerosis: role of dysbiosis and microbial metabolites on inflammation and disordered lipid metabolism. J Nutr Biochem 105:108991. https:\/\/doi.org\/10.1016\/j.jnutbio.2022.108991","journal-title":"J Nutr Biochem"},{"issue":"2","key":"10425_CR9","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ihj.2023.12.003","volume":"76","author":"S Majumder","year":"2024","unstructured":"Majumder S, Makwana RK, Shetty V, Mukherjee S, Narayan P (2024) Cardiovascular diseases and the heart\u2013gut cross talk. Indian Heart J 76(2):94\u2013100. https:\/\/doi.org\/10.1016\/j.ihj.2023.12.003","journal-title":"Indian Heart J"},{"key":"10425_CR10","doi-asserted-by":"publisher","first-page":"1235126","DOI":"10.3389\/fgstr.2023.1235126","volume":"2","author":"C Almeida","year":"2023","unstructured":"Almeida C, Gon\u00e7alves-Nobre JG, Alpuim Costa D, Barata P (2023) The potential links between human gut microbiota and cardiovascular health and disease-is there a gut-cardiovascular axis? Front Gastroenterol 2:1235126. https:\/\/doi.org\/10.3389\/fgstr.2023.1235126","journal-title":"Front Gastroenterol"},{"issue":"2","key":"10425_CR11","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1017\/S0029665113003911","volume":"73","author":"KM Tuohy","year":"2014","unstructured":"Tuohy KM, Fava F, Viola R (2014) The way to a Man\u2019s heart is through his gut microbiota\u2019\u2013dietary pro-and prebiotics for the management of cardiovascular risk. Proc Nutr Soc 73(2):172\u2013185. https:\/\/doi.org\/10.1017\/S0029665113003911","journal-title":"Proc Nutr Soc"},{"issue":"3","key":"10425_CR12","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1111\/1751-7915.13524","volume":"13","author":"H Xu","year":"2020","unstructured":"Xu H, Wang X, Feng W, Liu Q, Zhou S, Liu Q, Cai L (2020) The gut microbiota and its interactions with cardiovascular disease. Microb Biotechnol 13(3):637\u2013656. https:\/\/doi.org\/10.1111\/1751-7915.13524","journal-title":"Microb Biotechnol"},{"key":"10425_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jnutbio.2017.12.010","volume":"56","author":"ML Battson","year":"2018","unstructured":"Battson ML, Lee DM, Weir TL, Gentile CL (2018) The gut microbiota as a novel regulator of cardiovascular function and disease. J Nutr Biochem 56:1\u20135. https:\/\/doi.org\/10.1016\/j.jnutbio.2017.12.010","journal-title":"J Nutr Biochem"},{"issue":"3","key":"10425_CR14","doi-asserted-by":"publisher","first-page":"129","DOI":"10.15406\/mojph.2018.07.00218","volume":"7","author":"RB Singh","year":"2018","unstructured":"Singh RB, Fedacko J, Pella D, Jarcuska P, Mojto V, Al-bawareed OA, Chibisov S, Kharlitskaya EV, Abramova M (2018) The gut-brain-axis and the heart. MOJ Public Health 7(3):129\u2013138. https:\/\/doi.org\/10.15406\/mojph.2018.07.00218","journal-title":"MOJ Public Health"},{"issue":"13","key":"10425_CR15","doi-asserted-by":"publisher","first-page":"11312","DOI":"10.1074\/jbc.M211609200","volume":"278","author":"AJ Brown","year":"2003","unstructured":"Brown AJ, Goldsworthy SM, Barnes AA, Eilert MM, Tcheang L, Daniels D, Muir AI, Wigglesworth MJ, Kinghorn I, Fraser NJ, Pike NB (2003) The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem 278(13):11312\u201311319. https:\/\/doi.org\/10.1074\/jbc.M211609200","journal-title":"J Biol Chem"},{"key":"10425_CR16","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3389\/fphar.2018.00533","volume":"9","author":"M Li","year":"2018","unstructured":"Li M, Van Esch BC, Henricks PA, Folkerts G, Garssen J (2018) The anti-inflammatory effects of short chain fatty acids on lipopolysaccharide-or tumor necrosis factor \u03b1-stimulated endothelial cells via activation of GPR41\/43 and Inhibition of HDACs. Front Pharmacol 9:533. https:\/\/doi.org\/10.3389\/fphar.2018.00533","journal-title":"Front Pharmacol"},{"issue":"11","key":"10425_CR17","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1152\/physiolgenomics.00089.2016","volume":"48","author":"N Natarajan","year":"2016","unstructured":"Natarajan N, Hori D, Flavahan S, Steppan J, Flavahan NA, Berkowitz DE, Pluznick JL (2016) Microbial short chain fatty acid metabolites lower blood pressure via endothelial G protein-coupled receptor 41. Physiol Genomics 48(11):826\u2013834. https:\/\/doi.org\/10.1152\/physiolgenomics.00089.2016","journal-title":"Physiol Genomics"},{"issue":"1","key":"10425_CR18","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1161\/CIRCRESAHA.119.313965","volume":"125","author":"J Zubcevic","year":"2019","unstructured":"Zubcevic J, Richards EM, Yang T, Kim S, Sumners C, Pepine CJ, Raizada MK (2019) Impaired autonomic nervous system-microbiome circuit in hypertension: a premise for hypertension therapy. Circ Res 125(1):104\u2013116. https:\/\/doi.org\/10.1161\/CIRCRESAHA.119.313965","journal-title":"Circ Res"},{"issue":"25","key":"10425_CR19","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.1161\/01.CIR.0000074224.57016.01","volume":"107","author":"CG Nebigil","year":"2003","unstructured":"Nebigil CG, Jaffr\u00e9 F, Messaddeq N, Hickel P, Monassier L, Launay JM, Maroteaux L (2003) Overexpression of the serotonin 5-HT2B receptor in heart leads to abnormal mitochondrial function and cardiac hypertrophy. Circulation 107(25):3223\u20133229. https:\/\/doi.org\/10.1161\/01.CIR.0000074224.57016.01","journal-title":"Circulation"},{"issue":"2","key":"10425_CR20","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1124\/pr.111.004697","volume":"64","author":"SW Watts","year":"2012","unstructured":"Watts SW, Morrison SF, Davis RP, Barman SM (2012) Serotonin and blood pressure regulation. Pharmacol Rev 64(2):359\u2013388. https:\/\/doi.org\/10.1124\/pr.111.004697","journal-title":"Pharmacol Rev"},{"issue":"1","key":"10425_CR21","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1002\/cph4.7","volume":"15","author":"JP Krieger","year":"2025","unstructured":"Krieger JP, Daniels D, Lee S, Mastitskaya S, Langhans W (2025) Glucagon-Like Peptide\u20101 links ingestion, homeostasis, and the heart. Compr Physiol 15(1):e7. https:\/\/doi.org\/10.1002\/cph4.7","journal-title":"Compr Physiol"},{"issue":"1","key":"10425_CR22","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.cell.2016.02.011","volume":"165","author":"W Zhu","year":"2016","unstructured":"Zhu W, Gregory JC, Org E, Buffa JA, Gupta N, Wang Z, Li L, Fu X, Wu Y, Mehrabian M, Sartor RB (2016) Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk. Cell 165(1):111\u2013124. https:\/\/doi.org\/10.1016\/j.cell.2016.02.011","journal-title":"Cell"},{"issue":"1","key":"10425_CR23","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3390\/microorganisms10010108","volume":"10","author":"JY Yoo","year":"2022","unstructured":"Yoo JY, Sniffen S, McGill Percy KC, Pallaval VB, Chidipi B (2022) Gut dysbiosis and immune system in atherosclerotic cardiovascular disease (ACVD). Microorganisms 10(1):108. https:\/\/doi.org\/10.3390\/microorganisms10010108","journal-title":"Microorganisms"},{"issue":"8","key":"10425_CR24","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/nbt.2942","volume":"32","author":"J Li","year":"2014","unstructured":"Li J, Jia H, Cai X, Zhong H, Feng Q, Sunagawa S, Arumugam M, Kultima JR, Prifti E, Nielsen T, Juncker AS (2014) An integrated catalog of reference genes in the human gut Microbiome. Nat Biotechnol 32(8):834\u2013841. https:\/\/doi.org\/10.1038\/nbt.2942","journal-title":"Nat Biotechnol"},{"issue":"10","key":"10425_CR25","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/S1473-3099(15)00293-5","volume":"15","author":"P Hugon","year":"2015","unstructured":"Hugon P, Dufour JC, Colson P, Fournier PE, Sallah K, Raoult D (2015) A comprehensive repertoire of prokaryotic species identified in human beings. Lancet Infect Dis 15(10):1211\u20131219. https:\/\/doi.org\/10.1016\/S1473-3099(15)00293-5","journal-title":"Lancet Infect Dis"},{"key":"10425_CR26","doi-asserted-by":"publisher","unstructured":"Eckburg E PB, Bik EM, Bernstein CN, Purdom, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA (2005) Diversity of the human intestinal microbial flora. Science 308(5728):1635\u20131638. https:\/\/doi.org\/10.1126\/science.1110591","DOI":"10.1126\/science.1110591"},{"issue":"11","key":"10425_CR27","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1042\/BCJ20160510","volume":"474","author":"E Thursby","year":"2017","unstructured":"Thursby E, Juge N (2017) Introduction to the human gut microbiota. Biochem J 474(11):1823\u20131836. https:\/\/doi.org\/10.1042\/BCJ20160510","journal-title":"Biochem J"},{"issue":"4","key":"10425_CR28","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1152\/physiol.00004.2020","volume":"35","author":"BG Poll","year":"2020","unstructured":"Poll BG, Cheema MU, Pluznick JL (2020) Gut microbial metabolites and blood pressure regulation: focus on SCFAs and TMAO. Physiology 35(4):275\u2013284. https:\/\/doi.org\/10.1152\/physiol.00004.2020","journal-title":"Physiology"},{"issue":"21","key":"10425_CR29","doi-asserted-by":"publisher","first-page":"7357","DOI":"10.3390\/molecules27217357","volume":"27","author":"X Feng","year":"2022","unstructured":"Feng X, Ding L, Ma G, Zhang Y, Sun Y, Li Z, Tao X, Ali A, Wang D, Wu L (2022) Lactobacillus rhamnosus TR08 improves dyslipidemia in mice fed with a high fat diet by regulating the intestinal microbiota, reducing systemic inflammatory response, and promoting Sphingomholipid metabolism. Molecules 27(21):7357. https:\/\/doi.org\/10.3390\/molecules27217357","journal-title":"Molecules"},{"issue":"18","key":"10425_CR30","doi-asserted-by":"publisher","first-page":"3758","DOI":"10.3390\/nu14183758","volume":"14","author":"P Zhao","year":"2022","unstructured":"Zhao P, Zhao S, Tian J, Liu X (2022) Significance of gut microbiota and short-chain fatty acids in heart failure. Nutrients 14(18):3758. https:\/\/doi.org\/10.3390\/nu14183758","journal-title":"Nutrients"},{"issue":"7341","key":"10425_CR31","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature09922","volume":"472","author":"Z Wang","year":"2011","unstructured":"Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, DuGar B, Feldstein AE, Britt EB, Fu X, Chung YM, Wu Y (2011) Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472(7341):57\u201363. https:\/\/doi.org\/10.1038\/nature09922","journal-title":"Nature"},{"issue":"22","key":"10425_CR32","doi-asserted-by":"publisher","first-page":"12465","DOI":"10.3390\/ijms252212465","volume":"25","author":"K Rivera","year":"2024","unstructured":"Rivera K, Gonzalez L, Bravo L, Manjarres L, Andia ME (2024) The Gut\u2013Heart axis: molecular perspectives and implications for myocardial infarction. Int J Mol Sci 25(22):12465. https:\/\/doi.org\/10.3390\/ijms252212465","journal-title":"Int J Mol Sci"},{"issue":"9","key":"10425_CR33","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1080\/17474124.2017.1343143","volume":"11","author":"M Vancamelbeke","year":"2017","unstructured":"Vancamelbeke M, Vermeire S (2017) The intestinal barrier: a fundamental role in health and disease. Expert Rev Gastroenterol Hepatol 11(9):821\u2013834. https:\/\/doi.org\/10.1080\/17474124.2017.1343143","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"7","key":"10425_CR34","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.3390\/jcm12072567","volume":"12","author":"D Matsiras","year":"2023","unstructured":"Matsiras D, Bezati S, Ventoulis I, Verras C, Parissis J, Polyzogopoulou E (2023) Gut failure: A review of the pathophysiology and therapeutic potentials in the Gut\u2013Heart axis. J Clin Med 12(7):2567. https:\/\/doi.org\/10.3390\/jcm12072567","journal-title":"J Clin Med"},{"issue":"2","key":"10425_CR35","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1177\/1535370219900898","volume":"245","author":"M Onyszkiewicz","year":"2020","unstructured":"Onyszkiewicz M, Jaworska K, Ufnal M (2020) Short chain fatty acids and methylamines produced by gut microbiota as mediators and markers in the circulatory system. EBM 245(2):166\u2013175. https:\/\/doi.org\/10.1177\/1535370219900898","journal-title":"EBM"},{"issue":"4","key":"10425_CR36","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s12072-023-10496-y","volume":"17","author":"B Simbrunner","year":"2023","unstructured":"Simbrunner B, Caparr\u00f3s E, Neuwirth T, Schwabl P, K\u00f6nigshofer P, Bauer D, Marculescu R, Trauner M, Scheiner B, Stary G, Mandorfer M (2023) Bacterial translocation occurs early in cirrhosis and triggers a selective inflammatory response. Hepatol Int 17(4):1045\u20131056. https:\/\/doi.org\/10.1007\/s12072-023-10496-y","journal-title":"Hepatol Int"},{"key":"10425_CR37","doi-asserted-by":"publisher","first-page":"104652","DOI":"10.1016\/j.micpath.2020.104652","volume":"152","author":"YH Wang","year":"2021","unstructured":"Wang YH (2021) Current progress of research on intestinal bacterial translocation. Microb Pathog 152:104652. https:\/\/doi.org\/10.1016\/j.micpath.2020.104652","journal-title":"Microb Pathog"},{"issue":"6","key":"10425_CR38","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.tim.2016.02.001","volume":"24","author":"S Larcombe","year":"2016","unstructured":"Larcombe S, Hutton ML, Lyras D (2016) Involvement of bacteria other than clostridium difficile in antibiotic-associated diarrhoea. Trends Microbiol 24(6):463\u2013476. https:\/\/doi.org\/10.1016\/j.tim.2016.02.001","journal-title":"Trends Microbiol"},{"issue":"6","key":"10425_CR39","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.3390\/molecules25061340","volume":"25","author":"Z Breijyeh","year":"2020","unstructured":"Breijyeh Z, Jubeh B, Karaman R (2020) Resistance of gram-negative bacteria to current antibacterial agents and approaches to resolve it. Molecules 25(6):1340. https:\/\/doi.org\/10.3390\/molecules25061340","journal-title":"Molecules"},{"key":"10425_CR40","doi-asserted-by":"publisher","first-page":"100106","DOI":"10.1016\/j.medmic.2024.100106","volume":"20","author":"RH Lathakumari","year":"2024","unstructured":"Lathakumari RH, Vajravelu LK, Satheesan A, Ravi S, Thulukanam J (2024) Antibiotics and the gut microbiome: Understanding the impact on human health. Med Microecol 20:100106. https:\/\/doi.org\/10.1016\/j.medmic.2024.100106","journal-title":"Med Microecol"},{"issue":"11","key":"10425_CR41","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1136\/gutjnl-2016-312297","volume":"65","author":"G Ianiro","year":"2016","unstructured":"Ianiro G, Tilg H, Gasbarrini A (2016) Antibiotics as deep modulators of gut microbiota: between good and evil. Gut 65(11):1906\u20131915. https:\/\/doi.org\/10.1136\/gutjnl-2016-312297","journal-title":"Gut"},{"issue":"10","key":"10425_CR42","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.3390\/nu13103315","volume":"13","author":"Q Zhang","year":"2021","unstructured":"Zhang Q, Cheng L, Wang J, Hao M, Che H (2021) Antibiotic-induced gut microbiota dysbiosis damages the intestinal barrier, increasing food allergy in adult mice. Nutrients 13(10):3315. https:\/\/doi.org\/10.3390\/nu13103315","journal-title":"Nutrients"},{"issue":"1","key":"10425_CR43","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3349\/ymj.2018.59.1.4","volume":"59","author":"MY Yoon","year":"2018","unstructured":"Yoon MY, Yoon SS (2018) Disruption of the gut ecosystem by antibiotics. Yonsei Med J 59(1):4\u201312. https:\/\/doi.org\/10.3349\/ymj.2018.59.1.4","journal-title":"Yonsei Med J"},{"issue":"1","key":"10425_CR44","doi-asserted-by":"publisher","first-page":"164","DOI":"10.4103\/jehp.jehp_41_24","volume":"13","author":"DU Dumbre","year":"2024","unstructured":"Dumbre DU, Devi S, Chavan RG (2024) Effect of antibiotics on physical and physiological development of children under 5\u2014A scoping review. J Educ Health Promot 13(1):164. https:\/\/doi.org\/10.4103\/jehp.jehp_41_24","journal-title":"J Educ Health Promot"},{"issue":"1","key":"10425_CR45","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1053\/j.gastro.2016.03.006","volume":"151","author":"FI Scott","year":"2016","unstructured":"Scott FI, Horton DB, Mamtani R, Haynes K, Goldberg DS, Lee DY, Lewis JD (2016) Administration of antibiotics to children before age 2 years increases risk for childhood obesity. Gastroenterology 151(1):120\u2013129. https:\/\/doi.org\/10.1053\/j.gastro.2016.03.006","journal-title":"Gastroenterology"},{"key":"10425_CR46","doi-asserted-by":"publisher","first-page":"10410","DOI":"10.1038\/ncomms10410","volume":"7","author":"K Korpela","year":"2016","unstructured":"Korpela K, Salonen A, Virta LJ, Kekkonen RA, Forslund K, Bork P et al (2016) Intestinal Microbiome is related to lifetime antibiotic use in Finnish pre-school children. Nat Commun 7:10410. https:\/\/doi.org\/10.1038\/ncomms10410","journal-title":"Nat Commun"},{"key":"10425_CR47","doi-asserted-by":"publisher","unstructured":"Dominguez-Bello MG, Costello EK, Contreras M, Magris M, Hidalgo G, Fierer N, Knight R (2010) Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc. Natl. Acad. Sci. U.S.A 107(26):11971-5. https:\/\/doi.org\/10.1073\/pnas.1002601107","DOI":"10.1073\/pnas.1002601107"},{"issue":"6","key":"10425_CR48","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1111\/1471-0528.13601","volume":"123","author":"MB Azad","year":"2016","unstructured":"Azad MB, Konya T, Persaud RR, Guttman DS, Chari RS, Field CJ, Sears MR, Mandhane PJ, Turvey SE, Subbarao P, Becker AB (2016) Impact of maternal intrapartum antibiotics, method of birth and breastfeeding on gut microbiota during the first year of life: a prospective cohort study. BJOG 123(6):983\u2013993. https:\/\/doi.org\/10.1111\/1471-0528.13601","journal-title":"BJOG"},{"issue":"20","key":"10425_CR49","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1016\/j.jacc.2015.09.029","volume":"66","author":"YJ Cheng","year":"2015","unstructured":"Cheng YJ, Nie XY, Chen XM, Lin XX, Tang K, Zeng WT, Mei WY, Liu LJ, Long M, Yao FJ, Liu J (2015) The role of macrolide antibiotics in increasing cardiovascular risk. J Am Coll Cardiol 66(20):2173\u20132184. https:\/\/doi.org\/10.1016\/j.jacc.2015.09.029","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10425_CR50","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1093\/cid\/ciu914","volume":"60","author":"HW Chou","year":"2015","unstructured":"Chou HW, Wang JL, Chang CH, Lai CL, Lai MS, Chan KA (2015) Risks of cardiac arrhythmia and mortality among patients using new-generation macrolides, fluoroquinolones, and \u03b2-lactam\/\u03b2-lactamase inhibitors: a Taiwanese nationwide study. Clin Infect Dis 60(4):566\u2013577. https:\/\/doi.org\/10.1093\/cid\/ciu914","journal-title":"Clin Infect Dis"},{"issue":"21","key":"10425_CR51","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1001\/jama.2014.4304","volume":"311","author":"EM Mortensen","year":"2014","unstructured":"Mortensen EM, Halm EA, Pugh MJ, Copeland LA, Metersky M, Fine MJ, Johnson CS, Alvarez CA, Frei CR, Good C, Restrepo MI (2014) Association of Azithromycin with mortality and cardiovascular events among older patients hospitalized with pneumonia. JAMA 311(21):2199\u20132208. https:\/\/doi.org\/10.1001\/jama.2014.4304","journal-title":"JAMA"},{"issue":"4","key":"10425_CR52","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1093\/jac\/dkv423","volume":"71","author":"F Barbier","year":"2016","unstructured":"Barbier F, Pommier C, Essaied W, Garrouste-Orgeas M, Schwebel C, Ruckly S, Dumenil AS, Lemiale V, Mourvillier B, Clec\u2019h C, Darmon M (2016) Colonization and infection with extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae in ICU patients: what impact on outcomes and carbapenem exposure? J Antimicrob Chemother 71(4):1088\u20131097. https:\/\/doi.org\/10.1093\/jac\/dkv423","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"10425_CR53","doi-asserted-by":"publisher","first-page":"e035677","DOI":"10.1136\/bmjopen-2019-035677","volume":"10","author":"KT Elvers","year":"2020","unstructured":"Elvers KT, Wilson VJ, Hammond A, Duncan L, Huntley AL, Hay AD, Van Der Werf ET (2020) Antibiotic-induced changes in the human gut microbiota for the most commonly prescribed antibiotics in primary care in the UK: a systematic review. BMJ Open 10(9):e035677. https:\/\/doi.org\/10.1136\/bmjopen-2019-035677","journal-title":"BMJ Open"},{"issue":"8","key":"10425_CR54","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.3390\/antiox12081487","volume":"12","author":"MM Abd El-Emam","year":"2023","unstructured":"Abd El-Emam MM, Mostafa M, Farag AA, Youssef HS, El-Demerdash AS, Bayoumi H, Gebba MA, El-Halawani SM, Saleh AM, Badr AM, El Sayed S (2023) The potential effects of quercetin-loaded nanoliposomes on amoxicillin\/clavulanate-induced hepatic damage: targeting the Sirt1\/Nrf2\/Nf-\u03baB signaling pathway and microbiota modulation. Antioxidants 12(8):1487. https:\/\/doi.org\/10.3390\/antiox12081487","journal-title":"Antioxidants"},{"issue":"7","key":"10425_CR55","doi-asserted-by":"publisher","first-page":"e418","DOI":"10.1016\/S2665-9913(20)30064-3","volume":"2","author":"PM Wells","year":"2020","unstructured":"Wells PM, Adebayo AS, Bowyer RC, Freidin MB, Finckh A, Strowig T, Lesker TR, Alpizar-Rodriguez D, Gilbert B, Kirkham B, Cope AP (2020) Associations between gut microbiota and genetic risk for rheumatoid arthritis in the absence of disease: a cross-sectional study. Lancet Rheumatol the 2(7):e418\u2013e427. https:\/\/doi.org\/10.1016\/S2665-9913(20)30064-3","journal-title":"Lancet Rheumatol the"},{"issue":"12","key":"10425_CR56","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.3390\/nu16121800","volume":"16","author":"N Satthawiwat","year":"2024","unstructured":"Satthawiwat N, Jinato T, Sutheeworapong S, Tanpowpong N, Chuaypen N, Tangkijvanich P (2024) Distinct gut microbial signature and host genetic variants in association with liver fibrosis severity in patients with MASLD. Nutrients 16(12):1800. https:\/\/doi.org\/10.3390\/nu16121800","journal-title":"Nutrients"},{"issue":"1","key":"10425_CR57","doi-asserted-by":"publisher","first-page":"18842","DOI":"10.1038\/s41598-021-98262-8","volume":"11","author":"T Allain","year":"2021","unstructured":"Allain T, Fekete E, Sosnowski O, Desmonts de Lamache D, Motta JP, Leger D, Feener T, Reimer RA, Buret AG (2021) High-fat diet increases the severity of giardia infection in association with low-grade inflammation and gut microbiota dysbiosis. Sci Rep 11(1):18842. https:\/\/doi.org\/10.1038\/s41598-021-98262-8","journal-title":"Sci Rep"},{"issue":"730","key":"10425_CR58","doi-asserted-by":"publisher","first-page":"eadi9711","DOI":"10.1126\/scitranslmed.adi9711","volume":"16","author":"SK Bhattarai","year":"2024","unstructured":"Bhattarai SK, Du M, Zeamer AL, Morzfeld M, Kellogg B, Firat TD, Benjamin K, Bean A, Zimmerman JM, Mardi M, Vilbrun G SC (2024) Commensal antimicrobial resistance mediates Microbiome resilience to antibiotic disruption. Sci Transl Med 16(730):eadi9711. https:\/\/doi.org\/10.1126\/scitranslmed.adi9711","journal-title":"Sci Transl Med"},{"key":"10425_CR59","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.3389\/fmicb.2018.01948","volume":"9","author":"Y Shi","year":"2018","unstructured":"Shi Y, Kellingray L, Zhai Q, Gall GL, Narbad A, Zhao J, Zhang H, Chen W (2018) Structural and functional alterations in the microbial community and immunological consequences in a mouse model of antibiotic-induced dysbiosis. Front Microbiol 9:1948. https:\/\/doi.org\/10.3389\/fmicb.2018.01948","journal-title":"Front Microbiol"},{"key":"10425_CR60","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.micres.2017.04.001","volume":"200","author":"Y Shi","year":"2017","unstructured":"Shi Y, Zhai Q, Li D, Mao B, Liu X, Zhao J, Zhang H, Chen W (2017) Restoration of cefixime-induced gut microbiota changes by Lactobacillus cocktails and fructooligosaccharides in a mouse model. Microbiol Res 200:14\u201324. https:\/\/doi.org\/10.1016\/j.micres.2017.04.001","journal-title":"Microbiol Res"},{"issue":"4","key":"10425_CR61","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.cmet.2019.08.020","volume":"30","author":"DJ Cabral","year":"2019","unstructured":"Cabral DJ, Penumutchu S, Reinhart EM, Zhang C, Korry BJ, Wurster JI, Nilson R, Guang A, Sano WH, Rowan-Nash AD, Li H (2019) Microbial metabolism modulates antibiotic susceptibility within the murine gut Microbiome. Cell Metab 30(4):800\u2013823. https:\/\/doi.org\/10.1016\/j.cmet.2019.08.020","journal-title":"Cell Metab"},{"key":"10425_CR62","doi-asserted-by":"publisher","first-page":"114651","DOI":"10.1016\/j.envpol.2020.114651","volume":"265","author":"H Lin","year":"2020","unstructured":"Lin H, Wang Q, Yuan M, Liu L, Chen Z, Zhao Y, Das R, Duan Y, Xu X, Xue Y, Luo Y (2020) The prolonged disruption of a single-course amoxicillin on mice gut microbiota and resistome, and recovery by Inulin, bifidobacterium longum and fecal microbiota transplantation. Environ Pollut 265:114651. https:\/\/doi.org\/10.1016\/j.envpol.2020.114651","journal-title":"Environ Pollut"},{"issue":"10","key":"10425_CR63","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1136\/gutjnl-2018-317715","volume":"68","author":"F Hildebrand","year":"2019","unstructured":"Hildebrand F, Moitinho-Silva L, Blasche S, Jahn MT, Gossmann TI, Huerta-Cepas J, Hercog R, Luetge M, Bahram M, Pryszlak A, Alves RJ (2019) Antibiotics-induced monodominance of a novel gut bacterial order. Gut 68(10):1781\u20131790. https:\/\/doi.org\/10.1136\/gutjnl-2018-317715","journal-title":"Gut"},{"issue":"464","key":"10425_CR64","doi-asserted-by":"publisher","first-page":"eaao4755","DOI":"10.1126\/scitranslmed.aao4755","volume":"10","author":"NA Scott","year":"2018","unstructured":"Scott NA, Andrusaite A, Andersen P, Lawson M, Alcon-Giner C, Leclaire C, Caim S, Le Gall G, Shaw T, Connolly JP, Roe AJ (2018) Antibiotics induce sustained dysregulation of intestinal T cell immunity by perturbing macrophage homeostasis. Sci Transl Med 10(464):eaao4755. https:\/\/doi.org\/10.1126\/scitranslmed.aao4755","journal-title":"Sci Transl Med"},{"issue":"4","key":"10425_CR65","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1002\/jbmr.3635","volume":"34","author":"JD Schepper","year":"2019","unstructured":"Schepper JD, Collins FL, Rios-Arce ND, Raehtz S, Schaefer L, Gardinier JD, Britton RA, Parameswaran N, McCabe LR (2019) Probiotic Lactobacillus reuteri prevents postantibiotic bone loss by reducing intestinal dysbiosis and preventing barrier disruption. J Bone Min Res 34(4):681\u2013698. https:\/\/doi.org\/10.1002\/jbmr.3635","journal-title":"J Bone Min Res"},{"issue":"4","key":"10425_CR66","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.jhep.2013.11.034","volume":"60","author":"A Vrieze","year":"2014","unstructured":"Vrieze A, Out C, Fuentes S, Jonker L, Reuling I, Kootte RS, Van Nood E, Holleman F, Knaapen M, Romijn JA, Soeters MR (2014) Impact of oral Vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity. J Hepatol 60(4):824\u2013831. https:\/\/doi.org\/10.1016\/j.jhep.2013.11.034","journal-title":"J Hepatol"},{"issue":"1","key":"10425_CR67","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1093\/jac\/dkw383","volume":"72","author":"S Isaac","year":"2016","unstructured":"Isaac S, Scher JU, Djukovic A, Jim\u00e9nez N, Littman DR, Abramson SB, Pamer EG, Ubeda C (2016) Short-and long-term effects of oral Vancomycin on the human intestinal microbiota. J Antimicrob Chemother 72(1):128\u2013136. https:\/\/doi.org\/10.1093\/jac\/dkw383","journal-title":"J Antimicrob Chemother"},{"key":"10425_CR68","doi-asserted-by":"publisher","unstructured":"Palleja A, Mikkelsen KH, Forslund SK, Kashani A, Allin KH, Nielsen T, Hansen TH, Liang S, Feng Q, Zhang C, Pyl PT (2018) Recovery of gut microbiota of healthy adults following antibiotic exposure. Nat Microbiol 111255\u20131265. https:\/\/doi.org\/10.1038\/s41564-018-0257-9","DOI":"10.1038\/s41564-018-0257-9"},{"issue":"47","key":"10425_CR69","doi-asserted-by":"publisher","first-page":"3838","DOI":"10.1093\/eurheartj\/ehz231","volume":"40","author":"Y Heianza","year":"2019","unstructured":"Heianza Y, Zheng Y, Ma W, Rimm EB, Albert CM, Hu FB, Rexrode KM, Manson JE, Qi L (2019) Duration and life-stage of antibiotic use and risk of cardiovascular events in women. Eur Heart J 40(47):3838\u20133845. https:\/\/doi.org\/10.1093\/eurheartj\/ehz231","journal-title":"Eur Heart J"},{"key":"10425_CR70","doi-asserted-by":"publisher","unstructured":"Schembri S, Williamson PA, Short PM, Singanayagam A, Akram A, Taylor J, Singanayagam A, Hill AT, Chalmers JD (2013) Cardiovascular events after clarithromycin use in lower respiratory tract infections: analysis of two prospective cohort studies. BMJ 346. https:\/\/doi.org\/10.1136\/bmj.f1235","DOI":"10.1136\/bmj.f1235"},{"key":"10425_CR71","doi-asserted-by":"publisher","unstructured":"Svanstr\u00f6m H, Pasternak B, Hviid A (2014) Use of clarithromycin and roxithromycin and risk of cardiac death: cohort study. BMJ 349. https:\/\/doi.org\/10.1136\/bmj.g4930","DOI":"10.1136\/bmj.g4930"},{"issue":"10","key":"10425_CR72","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1164\/rccm.201402-0385CI","volume":"189","author":"RK Albert","year":"2014","unstructured":"Albert RK, Schuller JL, COPD Clinical Research Network (2014) Macrolide antibiotics and the risk of cardiac arrhythmias. AJRCCM 189(10):1173\u20131180. https:\/\/doi.org\/10.1164\/rccm.201402-0385CI","journal-title":"AJRCCM"},{"issue":"7","key":"10425_CR73","doi-asserted-by":"publisher","first-page":"E120","DOI":"10.1503\/cmaj.150901","volume":"188","author":"MH Trac","year":"2016","unstructured":"Trac MH, McArthur E, Jandoc R, Dixon SN, Nash DM, Hackam DG, Garg AX (2016) Macrolide antibiotics and the risk of ventricular arrhythmia in older adults. CMAJ 188(7):E120\u2013E129. https:\/\/doi.org\/10.1503\/cmaj.150901","journal-title":"CMAJ"},{"issue":"6","key":"10425_CR74","doi-asserted-by":"publisher","first-page":"e208199","DOI":"10.1001\/jamanetworkopen.2020.8199","volume":"3","author":"JG Zaroff","year":"2020","unstructured":"Zaroff JG, Cheetham TC, Palmetto N, Almers L, Quesenberry C, Schneider J, Gatto N, Corley DA (2020) Association of Azithromycin use with cardiovascular mortality. JAMA Netw Open 3(6):e208199. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.8199","journal-title":"JAMA Netw Open"},{"key":"10425_CR75","doi-asserted-by":"publisher","first-page":"723886","DOI":"10.3389\/fcvm.2021.723886","volume":"8","author":"B Wang","year":"2021","unstructured":"Wang B, Qiu J, Lian J, Yang X, Zhou J (2021) Gut metabolite trimethylamine-N-oxide in atherosclerosis: from mechanism to therapy. Front Cardiovasc Med 8:723886. https:\/\/doi.org\/10.3389\/fcvm.2021.723886","journal-title":"Front Cardiovasc Med"},{"issue":"6380","key":"10425_CR76","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1126\/science.aao5774","volume":"359","author":"L Zhao","year":"2018","unstructured":"Zhao L, Zhang F, Ding X, Wu G, Lam YY, Wang X, Fu H, Xue X, Lu C, Ma J, Yu L (2018) Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes. Science 359(6380):1151\u20131156. https:\/\/doi.org\/10.1126\/science.aao5774","journal-title":"Science"},{"issue":"1","key":"10425_CR77","doi-asserted-by":"publisher","first-page":"1897212","DOI":"10.1080\/19490976.2021.1897212","volume":"13","author":"A Nogal","year":"2021","unstructured":"Nogal A, Valdes AM, Menni C (2021) The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health. Gut Microbes 13(1):1897212. https:\/\/doi.org\/10.1080\/19490976.2021.1897212","journal-title":"Gut Microbes"},{"key":"10425_CR78","doi-asserted-by":"publisher","first-page":"104604","DOI":"10.1016\/j.phrs.2019.104604","volume":"152","author":"A Bartoszek","year":"2020","unstructured":"Bartoszek A, Von Moo E, Binienda A, Fabisiak A, Krajewska JB, Mosi\u0144ska P, Niewinna K, Tarasiuk A, Martemyanov K, Salaga M, Fichna J (2020) Free fatty acid receptors as new potential therapeutic target in inflammatory bowel diseases. Pharmacol Res 152:104604. https:\/\/doi.org\/10.1016\/j.phrs.2019.104604","journal-title":"Pharmacol Res"},{"key":"10425_CR79","unstructured":"Kaur KK, Allahbadia G, Singh M (2017) A review of nutrient metabolism in obesity with special emphasis on fatty acid metabolism. BAOJ Food Sci&Tec 1(001)"},{"issue":"19","key":"10425_CR80","doi-asserted-by":"publisher","first-page":"8030","DOI":"10.1073\/pnas.1016088108","volume":"108","author":"I Kimura","year":"2011","unstructured":"Kimura I, Inoue D, Maeda T, Hara T, Ichimura A, Miyauchi S, Kobayashi M, Hirasawa A, Tsujimoto G (2011) Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41). PNAS 108(19):8030\u20138035. https:\/\/doi.org\/10.1073\/pnas.1016088108","journal-title":"PNAS"},{"issue":"1","key":"10425_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18388\/abp.2018_2648","volume":"66","author":"W Ratajczak","year":"2019","unstructured":"Ratajczak W, Ry\u0142 A, Mizerski A, Walczakiewicz K, Sipak O, Laszczy\u0144ska M (2019) Immunomodulatory potential of gut microbiome-derived short-chain fatty acids (SCFAs). Acta Biochim Pol 66(1):1\u20132. https:\/\/doi.org\/10.18388\/abp.2018_2648","journal-title":"Acta Biochim Pol"},{"issue":"52","key":"10425_CR82","doi-asserted-by":"publisher","first-page":"21307","DOI":"10.1073\/pnas.1215689109","volume":"109","author":"S Craciun","year":"2012","unstructured":"Craciun S, Balskus EP (2012) Microbial conversion of choline to trimethylamine requires a glycyl radical enzyme. PNAS 109(52):21307\u201321312. https:\/\/doi.org\/10.1073\/pnas.1215689109","journal-title":"PNAS"},{"issue":"16","key":"10425_CR83","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1016\/j.jacc.2019.03.024","volume":"73","author":"WW Tang","year":"2019","unstructured":"Tang WW, B\u00e4ckhed F, Landmesser U, Hazen SL (2019) Intestinal microbiota in cardiovascular health and disease: JACC state-of-the-art review. JACC 73(16):2089\u20132105. https:\/\/doi.org\/10.1016\/j.jacc.2019.03.024","journal-title":"JACC"},{"issue":"9","key":"10425_CR84","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1111\/jth.14234","volume":"16","author":"W Zhu","year":"2018","unstructured":"Zhu W, Buffa JA, Wang Z, Warrier M, Schugar R, Shih DM, Gupta N, Gregory JC, Org E, Fu X, Li L (2018) Flavin monooxygenase 3, the host hepatic enzyme in the metaorganismal trimethylamine N-oxide\u2010generating pathway, modulates platelet responsiveness and thrombosis risk. J Thromb Haemost 16(9):1857\u20131872. https:\/\/doi.org\/10.1111\/jth.14234","journal-title":"J Thromb Haemost"},{"issue":"9","key":"10425_CR85","doi-asserted-by":"publisher","first-page":"e006347","DOI":"10.1161\/JAHA.117.006347","volume":"6","author":"ML Chen","year":"2017","unstructured":"Chen ML, Zhu XH, Ran L, Lang HD, Yi L, Mi MT (2017) Trimethylamine-N\u2010Oxide induces vascular inflammation by activating the NLRP3 inflammasome through the SIRT3\u2010SOD2\u2010mtROS signaling pathway. Am Heart J 6(9):e006347. https:\/\/doi.org\/10.1161\/JAHA.117.006347","journal-title":"Am Heart J"},{"issue":"6","key":"10425_CR86","doi-asserted-by":"publisher","first-page":"936","DOI":"10.17305\/bb.2023.8893","volume":"23","author":"YH Oktaviono","year":"2023","unstructured":"Oktaviono YH, Lamara AD, Saputra PB, Arnindita JN, Pasahari D, Saputra ME, Suasti NM (2023) The roles of trimethylamine-N-oxide in atherosclerosis and its potential therapeutic aspect: A literature review. Biomol Biomed 23(6):936. https:\/\/doi.org\/10.17305\/bb.2023.8893","journal-title":"Biomol Biomed"},{"key":"10425_CR87","doi-asserted-by":"publisher","first-page":"108278","DOI":"10.1016\/j.meatsci.2020.108278","volume":"171","author":"J Delgado","year":"2021","unstructured":"Delgado J, Ansorena D, Van Hecke T, Astiasar\u00e1n I, De Smet S, Est\u00e9vez M (2021) Meat lipids, NaCl and carnitine: do they unveil the conundrum of the association between red and processed meat intake and cardiovascular diseases? _Invited Rev Meat Sci 171:108278. https:\/\/doi.org\/10.1016\/j.meatsci.2020.108278","journal-title":"_Invited Rev Meat Sci"},{"issue":"2","key":"10425_CR88","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/mbio.02210-15","volume":"7","author":"ML Chen","year":"2016","unstructured":"Chen ML, Yi L, Zhang Y, Zhou X, Ran L, Yang J, Zhu JD, Zhang QY, Mi MT (2016) Resveratrol attenuates trimethylamine-N-oxide (TMAO)-induced atherosclerosis by regulating TMAO synthesis and bile acid metabolism via remodeling of the gut microbiota. MBio 7(2):10\u2013128. https:\/\/doi.org\/10.1128\/mbio.02210-15","journal-title":"MBio"},{"key":"10425_CR89","doi-asserted-by":"publisher","first-page":"28","DOI":"10.31665\/JFB.2018.2138","volume":"2","author":"Z He","year":"2018","unstructured":"He Z, Chen ZY (2018) The origin of trimethylamine-N-oxide (TMAO) and its role in development of atherosclerosis. J Food Bioact 2:28\u201336. https:\/\/doi.org\/10.31665\/JFB.2018.2138","journal-title":"J Food Bioact"},{"issue":"1","key":"10425_CR90","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/08830185.2021.1996573","volume":"41","author":"L Du","year":"2022","unstructured":"Du L, Lei X, Wang J, Wang L, Zhong Q, Fang X, Li P, Du B, Wang Y, Liao Z (2022) Lipopolysaccharides derived from gram-negative bacterial pool of human gut microbiota promote inflammation and obesity development. Int Rev Immunol 41(1):45\u201356. https:\/\/doi.org\/10.1080\/08830185.2021.1996573","journal-title":"Int Rev Immunol"},{"issue":"1","key":"10425_CR91","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1194\/jlr.M800156-JLR200","volume":"50","author":"S Ghoshal","year":"2009","unstructured":"Ghoshal S, Witta J, Zhong J, De Villiers W, Eckhardt E (2009) Chylomicrons promote intestinal absorption of lipopolysaccharides. J Lipid Res 50(1):90\u201397. https:\/\/doi.org\/10.1194\/jlr.M800156-JLR200","journal-title":"J Lipid Res"},{"issue":"4","key":"10425_CR92","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1128\/iai.73.4.2321-2326.2005","volume":"73","author":"JH Levels","year":"2005","unstructured":"Levels JH, Marquart JA, Abraham PR, Van den Ende AE, Molhuizen HO, Van Deventer SJ, Meijers JC (2005) Lipopolysaccharide is transferred from high-density to low-density lipoproteins by lipopolysaccharide-binding protein and phospholipid transfer protein. Infect Immun 73(4):2321\u20132326. https:\/\/doi.org\/10.1128\/iai.73.4.2321-2326.2005","journal-title":"Infect Immun"},{"key":"10425_CR93","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s00018-014-1762-5","volume":"72","author":"A P\u0142\u00f3ciennikowska","year":"2015","unstructured":"P\u0142\u00f3ciennikowska A, Hromada-Judycka A, Borz\u0119cka K, Kwiatkowska K (2015) Co-operation of TLR4 and raft proteins in LPS-induced pro-inflammatory signaling. Cell Mol Life Sci 72:557\u2013581. https:\/\/doi.org\/10.1007\/s00018-014-1762-5","journal-title":"Cell Mol Life Sci"},{"key":"10425_CR94","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.redox.2016.06.006","volume":"9","author":"C Li","year":"2016","unstructured":"Li C, Zhang WJ, Frei B (2016) Quercetin inhibits LPS-induced adhesion molecule expression and oxidant production in human aortic endothelial cells by p38-mediated Nrf2 activation and antioxidant enzyme induction. Redox Biol 9:104\u2013113. https:\/\/doi.org\/10.1016\/j.redox.2016.06.006","journal-title":"Redox Biol"},{"key":"10425_CR95","doi-asserted-by":"publisher","first-page":"845942","DOI":"10.3389\/fcvm.2022.845942","volume":"9","author":"Y Gui","year":"2022","unstructured":"Gui Y, Zheng H, Cao RY (2022) Foam cells in atherosclerosis: novel insights into its origins, consequences, and molecular mechanisms. Front Cardiovasc Med 9:845942. https:\/\/doi.org\/10.3389\/fcvm.2022.845942","journal-title":"Front Cardiovasc Med"},{"issue":"11","key":"10425_CR96","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.3390\/molecules27113401","volume":"27","author":"Y Shulpekova","year":"2022","unstructured":"Shulpekova Y, Zharkova M, Tkachenko P, Tikhonov I, Stepanov A, Synitsyna A, Izotov A, Butkova T, Shulpekova N, Lapina N, Nechaev V (2022) The role of bile acids in the human body and in the development of diseases. Molecules 27(11):3401. https:\/\/doi.org\/10.3390\/molecules27113401","journal-title":"Molecules"},{"issue":"2","key":"10425_CR97","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.apsb.2015.01.004","volume":"5","author":"L Ding","year":"2015","unstructured":"Ding L, Yang L, Wang Z, Huang W (2015) Bile acid nuclear receptor FXR and digestive system diseases. Acta Pharm Sin B 5(2):135\u2013144. https:\/\/doi.org\/10.1016\/j.apsb.2015.01.004","journal-title":"Acta Pharm Sin B"},{"issue":"2","key":"10425_CR98","doi-asserted-by":"publisher","first-page":"144","DOI":"10.20892\/j.issn.2095-3941.2023.0394","volume":"21","author":"Y Song","year":"2023","unstructured":"Song Y, Lau HC, Zhang X, Yu J (2023) Bile acids, gut microbiota, and therapeutic insights in hepatocellular carcinoma. Cancer Biol Med 21(2):144. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2023.0394","journal-title":"Cancer Biol Med"},{"issue":"4","key":"10425_CR99","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1507\/endocrj.EJ22-0544","volume":"70","author":"H Yu","year":"2023","unstructured":"Yu H, Nie R, Shen C (2023) The role of bile acids in regulating glucose and lipid metabolism. Endocr J 70(4):359\u2013374. https:\/\/doi.org\/10.1507\/endocrj.EJ22-0544","journal-title":"Endocr J"},{"key":"10425_CR100","doi-asserted-by":"publisher","first-page":"1027212","DOI":"10.3389\/fphar.2022.1027212","volume":"13","author":"R Gao","year":"2022","unstructured":"Gao R, Meng X, Xue Y, Mao M, Liu Y, Tian X, Sui B, Li X, Zhang P (2022) Bile acids-gut microbiota crosstalk contributes to the improvement of type 2 diabetes mellitus. Front Pharmacol 13:1027212. https:\/\/doi.org\/10.3389\/fphar.2022.1027212","journal-title":"Front Pharmacol"},{"issue":"1","key":"10425_CR101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14336\/AD.2023.0603","volume":"15","author":"P Minoretti","year":"2024","unstructured":"Minoretti P, Emanuele E (2024) Bile acids in cardiovascular diseases: don\u2019t forget hyocholic acid. Aging Dis 15(1):1. https:\/\/doi.org\/10.14336\/AD.2023.0603","journal-title":"Aging Dis"},{"key":"10425_CR102","doi-asserted-by":"publisher","first-page":"18014","DOI":"10.1038\/nrdp.2018.14","volume":"4","author":"S Oparil","year":"2018","unstructured":"Oparil S, Acelajado MC, Bakris GL, Berlowitz DR, C\u00edfkov\u00e1 R, Dominiczak AF, Grassi G, Jordan J, Poulter NR, Rodgers A, Whelton PK (2018) Hypertens Nat Rev Dis Primers 4:18014. https:\/\/doi.org\/10.1038\/nrdp.2018.14","journal-title":"Hypertens Nat Rev Dis Primers"},{"issue":"7","key":"10425_CR103","doi-asserted-by":"publisher","first-page":"3698","DOI":"10.3390\/ijms23073698","volume":"23","author":"J Maiuolo","year":"2022","unstructured":"Maiuolo J, Carresi C, Gliozzi M, Mollace R, Scarano F, Scicchitano M, Macr\u00ec R, Nucera S, Bosco F, Oppedisano F, Ruga S (2022) The contribution of gut microbiota and endothelial dysfunction in the development of arterial hypertension in animal models and in humans. Int J Mol Sci 23(7):3698. https:\/\/doi.org\/10.3390\/ijms23073698","journal-title":"Int J Mol Sci"},{"key":"10425_CR104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40168-016-0222-x","volume":"5","author":"J Li","year":"2017","unstructured":"Li J, Zhao F, Wang Y, Chen J, Tao J, Tian G, Wu S, Liu W, Cui Q, Geng B, Zhang W (2017) Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome 5:1\u20139. https:\/\/doi.org\/10.1186\/s40168-016-0222-x","journal-title":"Microbiome"},{"issue":"6","key":"10425_CR105","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1042\/CS20180087","volume":"132","author":"S Kim","year":"2018","unstructured":"Kim S, Goel R, Kumar A, Qi Y, Lobaton G, Hosaka K, Mohammed M, Handberg EM, Richards EM, Pepine CJ, Raizada MK (2018) Imbalance of gut Microbiome and intestinal epithelial barrier dysfunction in patients with high blood pressure. Clin Sci 132(6):701\u2013718. https:\/\/doi.org\/10.1042\/CS20180087","journal-title":"Clin Sci"},{"issue":"10","key":"10425_CR106","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1161\/CIRCULATIONAHA.116.024545","volume":"135","author":"FZ Marques","year":"2017","unstructured":"Marques FZ, Nelson E, Chu PY, Horlock D, Fiedler A, Ziemann M, Tan JK, Kuruppu S, Rajapakse NW, El-Osta A, Mackay CR (2017) High-fiber diet and acetate supplementation change the gut microbiota and prevent the development of hypertension and heart failure in hypertensive mice. Circulation 135(10):964\u2013977. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.024545","journal-title":"Circulation"},{"issue":"6","key":"10425_CR107","doi-asserted-by":"publisher","first-page":"874","DOI":"10.3390\/biology12060874","volume":"12","author":"E Brociek","year":"2023","unstructured":"Brociek E, Tymi\u0144ska A, Giordani AS, Caforio AL, Wojnicz R, Grabowski M, Oziera\u0144ski K (2023) Myocarditis: etiology, pathogenesis, and their implications in clinical practice. Biology 12(6):874. https:\/\/doi.org\/10.3390\/biology12060874","journal-title":"Biology"},{"key":"10425_CR108","doi-asserted-by":"publisher","first-page":"1382502","DOI":"10.3389\/fgene.2024.1382502","volume":"15","author":"K Li","year":"2024","unstructured":"Li K, Liu P, Wang X, Zheng Z, Liu M, Ye J, Zhu L (2024) Causal role of gut microbiota, serum metabolites, immunophenotypes in myocarditis: a Mendelian randomization study. Front Genet 15:1382502. https:\/\/doi.org\/10.3389\/fgene.2024.1382502","journal-title":"Front Genet"},{"issue":"6","key":"10425_CR109","doi-asserted-by":"publisher","first-page":"H1227","DOI":"10.1152\/ajpheart.00612.2020","volume":"319","author":"CV Lewis","year":"2020","unstructured":"Lewis CV, Taylor WR (2020) Intestinal barrier dysfunction as a therapeutic target for cardiovascular disease. Am J Physiol Heart Circ Physiol 319(6):H1227\u2013H1233. https:\/\/doi.org\/10.1152\/ajpheart.00612.2020","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10425_CR110","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.phrs.2018.11.042","volume":"139","author":"XF Hu","year":"2019","unstructured":"Hu XF, Zhang WY, Wen Q, Chen WJ, Wang ZM, Chen J, Zhu F, Liu K, Cheng LX, Yang J, Shu YW (2019) Fecal microbiota transplantation alleviates myocardial damage in myocarditis by restoring the microbiota composition. Pharmacol Res 139:412\u2013421. https:\/\/doi.org\/10.1016\/j.phrs.2018.11.042","journal-title":"Pharmacol Res"},{"issue":"6","key":"10425_CR111","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1536\/ihj.16-414","volume":"57","author":"T Yamashita","year":"2016","unstructured":"Yamashita T, Emoto T, Sasaki N, Hirata KI (2016) Gut microbiota and coronary artery disease. Int Heart J 57(6):663\u2013671. https:\/\/doi.org\/10.1536\/ihj.16-414","journal-title":"Int Heart J"},{"issue":"3","key":"10425_CR112","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.3390\/ijms24031940","volume":"24","author":"M Canyelles","year":"2023","unstructured":"Canyelles M, Borr\u00e0s C, Rotllan N, Tondo M, Escol\u00e0-Gil JC, Blanco-Vaca F (2023) Gut microbiota-derived TMAO: a causal factor promoting atherosclerotic cardiovascular disease? Int J Mol Sci 24(3):1940. https:\/\/doi.org\/10.3390\/ijms24031940","journal-title":"Int J Mol Sci"},{"key":"10425_CR113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11883-020-00892-2","volume":"22","author":"H Liu","year":"2020","unstructured":"Liu H, Zhuang J, Tang P, Li J, Xiong X, Deng H (2020) The role of the gut microbiota in coronary heart disease. Curr Atheroscler Rep 22:1\u20132. https:\/\/doi.org\/10.1007\/s11883-020-00892-2","journal-title":"Curr Atheroscler Rep"},{"issue":"12","key":"10425_CR114","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/s41564-018-0272-x","volume":"3","author":"K Kasahara","year":"2018","unstructured":"Kasahara K, Krautkramer KA, Org E, Romano KA, Kerby RL, Vivas EI, Mehrabian M, Denu JM, B\u00e4ckhed F, Lusis AJ, Rey FE (2018) Interactions between roseburia intestinalis and diet modulate atherogenesis in a murine model. Nat Microbiol 3(12):1461\u20131471. https:\/\/doi.org\/10.1038\/s41564-018-0272-x","journal-title":"Nat Microbiol"},{"issue":"1","key":"10425_CR115","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.chom.2022.11.015","volume":"31","author":"Y Zhu","year":"2023","unstructured":"Zhu Y, Dwidar M, Nemet I, Buffa JA, Sangwan N, Li XS, Anderson JT, Romano KA, Fu X, Funabashi M, Wang Z (2023) Two distinct gut microbial pathways contribute to meta-organismal production of Phenylacetylglutamine with links to cardiovascular disease. Cell Host Microbe 31(1):18\u201332. https:\/\/doi.org\/10.1016\/j.chom.2022.11.015","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10425_CR116","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41392-023-01613-2","volume":"8","author":"Y Lu","year":"2023","unstructured":"Lu Y, Yang W, Qi Z, Gao R, Tong J, Gao T, Zhang Y, Sun A, Zhang S, Ge J (2023) Gut microbe-derived metabolite indole-3-carboxaldehyde alleviates atherosclerosis. Signal Transduct Target Ther 8(1):378. https:\/\/doi.org\/10.1038\/s41392-023-01613-2","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"10425_CR117","doi-asserted-by":"publisher","first-page":"e00100","DOI":"10.1128\/msystems.00100-22","volume":"7","author":"B Sun","year":"2022","unstructured":"Sun B, Ma T, Li Y, Yang N, Li B, Zhou X, Guo S, Zhang S, Kwok LY, Sun Z, Zhang H (2022) Bifidobacterium lactis Probio-M8 adjuvant treatment confers added benefits to patients with coronary artery disease via target modulation of the gut-heart\/-brain axes. Msystems 7(2):e00100\u2013e00122. https:\/\/doi.org\/10.1128\/msystems.00100-22","journal-title":"Msystems"},{"key":"10425_CR118","doi-asserted-by":"publisher","unstructured":"Ottaviani G, Buja LM (2022) Congenital heart disease: pathology, natural history, and interventions. Cardiovasc Pathol 223\u2013264. https:\/\/doi.org\/10.1016\/B978-0-12-822224-9.00011-6","DOI":"10.1016\/B978-0-12-822224-9.00011-6"},{"key":"10425_CR119","doi-asserted-by":"publisher","first-page":"1152349","DOI":"10.3389\/fcimb.2023.1152349","volume":"13","author":"QL Zhang","year":"2023","unstructured":"Zhang QL, Chen XH, Zhou SJ, Lei YQ, Huang JS, Chen Q, Cao H (2023) Relationship between disorders of the intestinal microbiota and heart failure in infants with congenital heart disease. Front Cell Infect Microbiol 13:1152349. https:\/\/doi.org\/10.3389\/fcimb.2023.1152349","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"10425_CR120","doi-asserted-by":"publisher","first-page":"5339","DOI":"10.1038\/s41598-021-84901-7","volume":"11","author":"T Wang","year":"2021","unstructured":"Wang T, Chen L, Huang P, Yang T, Zhang S, Zhao L, Chen L, Ye Z, Luo L, Qin J (2021) Association of maternal gut microbiota and plasma metabolism with congenital heart disease in offspring: A multi-omic analysis. Sci Rep 11(1):5339. https:\/\/doi.org\/10.1038\/s41598-021-84901-7","journal-title":"Sci Rep"},{"issue":"1","key":"10425_CR121","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s40168-022-01437-2","volume":"10","author":"Y Huang","year":"2022","unstructured":"Huang Y, Lu W, Zeng M, Hu X, Su Z, Liu Y, Liu Z, Yuan J, Li L, Zhang X, Huang L (2022) Mapping the early life gut Microbiome in neonates with critical congenital heart disease: multiomics insights and implications for host metabolic and immunological health. Microbiome 10(1):245. https:\/\/doi.org\/10.1186\/s40168-022-01437-2","journal-title":"Microbiome"},{"issue":"4","key":"10425_CR122","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3390\/life14040527","volume":"14","author":"G Nayak","year":"2024","unstructured":"Nayak G, Dimitriadis K, Pyrpyris N, Manti M, Kamperidis N, Kamperidis V, Ziakas A, Tsioufis K (2024) Gut Microbiome and its role in valvular heart disease: not a gutted. Relatsh Life 14(4):527. https:\/\/doi.org\/10.3390\/life14040527","journal-title":"Relatsh Life"},{"issue":"2","key":"10425_CR123","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3390\/jcm12020407","volume":"12","author":"Y Guo","year":"2023","unstructured":"Guo Y, Xu S, Zhan H, Chen H, Hu P, Zhou D, Dai H, Liu X, Hu W, Zhu G, Suzuki T (2023) Trimethylamine N-Oxide levels are associated with severe aortic stenosis and predict long-term adverse outcome. J Clin Med 12(2):407. https:\/\/doi.org\/10.3390\/jcm12020407","journal-title":"J Clin Med"},{"issue":"5","key":"10425_CR124","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1080\/00015385.2020.1853968","volume":"76","author":"D Kocyigit","year":"2021","unstructured":"Kocyigit D, Tokgozoglu L, Gurses KM, Stahlman M, Boren J, Soyal MF, Canp\u0131nar H, Guc D, Saglam Ayhan A, Hazirolan T, Ozer N (2021) Association of dietary and gut microbiota-related metabolites with calcific aortic stenosis. Acta Cardiol 76(5):544\u2013552. https:\/\/doi.org\/10.1080\/00015385.2020.1853968","journal-title":"Acta Cardiol"},{"key":"10425_CR125","doi-asserted-by":"publisher","first-page":"643092","DOI":"10.3389\/fcimb.2021.643092","volume":"11","author":"XR Shi","year":"2021","unstructured":"Shi XR, Chen BY, Lin WZ, Li YL, Wang YL, Liu Y, Huang JJ, Zhang WW, Ma XX, Shao S, Li RG (2021) Microbiota in gut, oral cavity, and mitral valves are associated with rheumatic heart disease. Front Cell Infect Microbiol 11:643092. https:\/\/doi.org\/10.3389\/fcimb.2021.643092","journal-title":"Front Cell Infect Microbiol"},{"issue":"6","key":"10425_CR126","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.3390\/biomedicines12061217","volume":"12","author":"M Perticone","year":"2024","unstructured":"Perticone M, Gigliotti S, Shehaj E, Maio R, Suraci E, Miceli S, Andreozzi F, Matera G, Perticone F (2024) Gut permeability and Immune-Mediated inflammation in heart failure. Biomedicines 12(6):1217. https:\/\/doi.org\/10.3390\/biomedicines12061217","journal-title":"Biomedicines"},{"key":"10425_CR127","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.toxlet.2016.12.017","volume":"267","author":"M Makrecka-Kuka","year":"2017","unstructured":"Makrecka-Kuka M, Volska K, Antone U, Vilskersts R, Grinberga S, Bandere D, Liepinsh E, Dambrova M (2017) Trimethylamine N-oxide impairs pyruvate and fatty acid oxidation in cardiac mitochondria. Toxicol Lett 267:32\u201338. https:\/\/doi.org\/10.1016\/j.toxlet.2016.12.017","journal-title":"Toxicol Lett"},{"issue":"2","key":"10425_CR128","doi-asserted-by":"publisher","first-page":"e002767","DOI":"10.1161\/JAHA.115.002767","volume":"5","author":"MM Seldin","year":"2016","unstructured":"Seldin MM, Meng Y, Qi H, Zhu W, Wang Z, Hazen SL, Lusis AJ, Shih DM (2016) Trimethylamine N-oxide promotes vascular inflammation through signaling of mitogen\u2010activated protein kinase and nuclear factor\u2010\u03baB. Am Heart J 5(2):e002767. https:\/\/doi.org\/10.1161\/JAHA.115.002767","journal-title":"Am Heart J"},{"issue":"3","key":"10425_CR129","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/s41374-018-0091-y","volume":"99","author":"Z Li","year":"2019","unstructured":"Li Z, Wu Z, Yan J, Liu H, Liu Q, Deng Y, Ou C, Chen M (2019) Gut microbe-derived metabolite trimethylamine N-oxide induces cardiac hypertrophy and fibrosis. Lab Investig 99(3):346\u2013357. https:\/\/doi.org\/10.1038\/s41374-018-0091-y","journal-title":"Lab Investig"},{"issue":"17","key":"10425_CR130","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1056\/NEJMoa1109400","volume":"368","author":"WW Tang","year":"2013","unstructured":"Tang WW, Wang Z, Levison BS, Koeth RA, Britt EB, Fu X, Wu Y, Hazen SL (2013) Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med 368(17):1575\u20131584. https:\/\/doi.org\/10.1056\/NEJMoa1109400","journal-title":"N Engl J Med"},{"issue":"18","key":"10425_CR131","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1161\/CIRCULATIONAHA.120.052671","volume":"143","author":"AN Carley","year":"2021","unstructured":"Carley AN, Maurya SK, Fasano M, Wang Y, Selzman CH, Drakos SG, Lewandowski ED (2021) Short-chain fatty acids outpace ketone oxidation in the failing heart. Circulation 143(18):1797\u20131808. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.052671","journal-title":"Circulation"},{"key":"10425_CR132","doi-asserted-by":"publisher","unstructured":"Awoyemi A, Mayerhofer C, Felix AS, Hov JR, Moscavitch SD, Lappeg\u00e5rd KT, Hovland A, Halvorsen S, Halvorsen B, Gregersen I, Svardal A (2021) Rifaximin or Saccharomyces boulardii in heart failure with reduced ejection fraction: Results from the randomized GutHeart trial. EBioMedicine 70. https:\/\/doi.org\/10.1016\/j.ebiom.2021.103511","DOI":"10.1016\/j.ebiom.2021.103511"},{"issue":"3","key":"10425_CR133","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1161\/CIRCHEARTFAILURE.113.000978","volume":"7","author":"XT Gan","year":"2014","unstructured":"Gan XT, Ettinger G, Huang CX, Burton JP, Haist JV, Rajapurohitam V, Sidaway JE, Martin G, Gloor GB, Swann JR, Reid G (2014) Probiotic administration attenuates myocardial hypertrophy and heart failure after myocardial infarction in the rat. Circ Heart Fail 7(3):491\u2013499. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.113.000978","journal-title":"Circ Heart Fail"},{"issue":"4","key":"10425_CR134","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.3390\/nu12041107","volume":"12","author":"P Markowiak-Kope\u0107","year":"2020","unstructured":"Markowiak-Kope\u0107 P, \u015ali\u017cewska K (2020) The effect of probiotics on the production of short-chain fatty acids by human intestinal Microbiome. Nutrients 12(4):1107. https:\/\/doi.org\/10.3390\/nu12041107","journal-title":"Nutrients"},{"issue":"1","key":"10425_CR135","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13073-021-00921-y","volume":"13","author":"W Ma","year":"2021","unstructured":"Ma W, Nguyen LH, Song M, Wang DD, Franzosa EA, Cao Y, Joshi A, Drew DA, Mehta R, Ivey KL, Strate LL (2021) Dietary fiber intake, the gut microbiome, and chronic systemic inflammation in a cohort of adult men. NPJ Genom Med 13(1):102. https:\/\/doi.org\/10.1186\/s13073-021-00921-y","journal-title":"NPJ Genom Med"},{"issue":"1","key":"10425_CR136","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41522-022-00287-y","volume":"8","author":"RR Lim","year":"2022","unstructured":"Lim RR, Park MA, Wong LH, Haldar S, Lim KJ, Nagarajan N, Henry CJ, Jiang YR, Moskvin OV (2022) Gut Microbiome responses to dietary intervention with hypocholesterolemic vegetable oils. Npj Biofilms Microbiomes 8(1):24. https:\/\/doi.org\/10.1038\/s41522-022-00287-y","journal-title":"Npj Biofilms Microbiomes"},{"issue":"1","key":"10425_CR137","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1093\/ajcn\/69.1.30","volume":"69","author":"L Brown","year":"1999","unstructured":"Brown L, Rosner B, Willett WW, Sacks FM (1999) Cholesterol-lowering effects of dietary fiber: a meta-analysis. AJCN 69(1):30\u201342. https:\/\/doi.org\/10.1093\/ajcn\/69.1.30","journal-title":"AJCN"},{"issue":"4","key":"10425_CR138","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1136\/gutjnl-2020-323617","volume":"71","author":"SC Ng","year":"2022","unstructured":"Ng SC, Xu Z, Mak JW, Yang K, Liu Q, Zuo T, Tang W, Lau L, Lui RN, Wong SH, Tse YK (2022) Microbiota engraftment after faecal microbiota transplantation in obese subjects with type 2 diabetes: a 24-week, double-blind, randomised controlled trial. Gut 71(4):716\u2013723. https:\/\/doi.org\/10.1136\/gutjnl-2020-323617","journal-title":"Gut"},{"key":"10425_CR139","doi-asserted-by":"publisher","unstructured":"Sun B, Li L, Zhou X (2018) Comparative analysis of the gut microbiota in distinct Statin response patients in East China. J Microbiol 56:886\u2013\u200992 https:\/\/doi.org\/10.1007\/s12275-018-8152-x","DOI":"10.1007\/s12275-018-8152-x"},{"issue":"11","key":"10425_CR140","doi-asserted-by":"publisher","first-page":"5935","DOI":"10.3390\/ijms23115935","volume":"23","author":"S Park","year":"2022","unstructured":"Park S, Zhang T, Yue Y, Wu X (2022) Effects of bile acid modulation by dietary fat, cholecystectomy, and bile acid sequestrant on energy, glucose, and lipid metabolism and gut microbiota in mice. Int J Mol Sci 23(11):5935. https:\/\/doi.org\/10.3390\/ijms23115935","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10425_CR141","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/mbio.02392-17","volume":"9","author":"X Tong","year":"2018","unstructured":"Tong X, Xu J, Lian F, Yu X, Zhao Y, Xu L, Zhang M, Zhao X, Shen J, Wu S, Pang X (2018) Structural alteration of gut microbiota during the amelioration of human type 2 diabetes with hyperlipidemia by Metformin and a traditional Chinese herbal formula: a multicenter, randomized, open label clinical trial. MBio 9(3):10\u2013128. https:\/\/doi.org\/10.1128\/mbio.02392-17","journal-title":"MBio"},{"issue":"12","key":"10425_CR142","doi-asserted-by":"publisher","first-page":"6837","DOI":"10.3390\/ijms23126837","volume":"20","author":"E Ermolenko","year":"2022","unstructured":"Ermolenko E, Simanenkova A, Voropaeva L, Lavrenova N, Kotyleva M, Minasian S, Chernikova A, Timkina N, Gladyshev N, Dmitriev A, Suvorov A (2022) Metformin influence on the intestinal microbiota and organism of rats with metabolic syndrome. Int J Mol Sci Jun 20(12):6837. https:\/\/doi.org\/10.3390\/ijms23126837","journal-title":"Int J Mol Sci Jun"},{"key":"10425_CR143","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11906-020-01080-y","volume":"22","author":"A Dixon","year":"2020","unstructured":"Dixon A, Robertson K, Yung A, Que M, Randall H, Wellalagodage D, Cox T, Robertson D, Chi C, Sun J (2020) Efficacy of probiotics in patients of cardiovascular disease risk: a systematic review and meta-analysis. Curr Hypertens Rep 22:1\u201327. https:\/\/doi.org\/10.1007\/s11906-020-01080-y","journal-title":"Curr Hypertens Rep"},{"issue":"4","key":"10425_CR144","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.3390\/molecules26041172","volume":"26","author":"A Oniszczuk","year":"2021","unstructured":"Oniszczuk A, Oniszczuk T, Gancarz M, Szyma\u0144ska J (2021) Role of gut microbiota, probiotics and prebiotics in the cardiovascular diseases. Molecules 26(4):1172. https:\/\/doi.org\/10.3390\/molecules26041172","journal-title":"Molecules"},{"key":"10425_CR145","doi-asserted-by":"publisher","unstructured":"Saini M, Singh SK, Yadav HK, Dave P, Gupta M, Bhat AA, Thapa R, Singla N, Purohit M, Gupta G (2024) Role of Synbiotics in Cardiovascular Diseases. InSynbiotics in Human Health: Biology to Drug Delivery 137\u2013153 https:\/\/doi.org\/10.1007\/978-981-99-5575-6_6","DOI":"10.1007\/978-981-99-5575-6_6"},{"key":"10425_CR146","doi-asserted-by":"publisher","first-page":"1321395","DOI":"10.3389\/fimmu.2024.1321395","volume":"15","author":"A Luqman","year":"2024","unstructured":"Luqman A, Hassan A, Ullah M, Naseem S, Ullah M, Zhang L, Din AU, Ullah K, Ahmad W, Wang G (2024) Role of the intestinal Microbiome and its therapeutic intervention in cardiovascular disorder. Front Immunol 15:1321395. https:\/\/doi.org\/10.3389\/fimmu.2024.1321395","journal-title":"Front Immunol"},{"key":"10425_CR147","doi-asserted-by":"publisher","unstructured":"Mousavi Ghahfarrokhi SS, Mohamadzadeh M, Samadi N, Fazeli MR, Khaki S, Khameneh B, Khameneh Bagheri R (2024) Management of cardiovascular diseases by Short-Chain fatty acid postbiotics. Curr Nutr Rep 1\u201320. https:\/\/doi.org\/10.1007\/s13668-024-00531-1","DOI":"10.1007\/s13668-024-00531-1"},{"key":"10425_CR148","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13017-023-00518-3","volume":"18","author":"Worldwide Antimicrobial Resistance National\/International Network Group (WARNING) Collaborators","year":"2023","unstructured":"Worldwide Antimicrobial Resistance National\/International Network Group (WARNING) Collaborators (2023) Ten golden rules for optimal antibiotic use in hospital settings: the WARNING call to action. World J Emerg Surg 18:50. https:\/\/doi.org\/10.1186\/s13017-023-00518-3","journal-title":"World J Emerg Surg"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10425-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-10425-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10425-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T16:32:28Z","timestamp":1766853148000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-10425-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,17]]},"references-count":148,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10425"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-10425-2","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,17]]},"assertion":[{"value":"10 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"319"}}